Strains

A 3,000+ strain library, whole-genome sequenced and archived — with proprietary, clinically documented strains available for exclusive licensing.

Lactobacillus rhamnosus CCFM1219

Key Benefits

• Reduces high-fat-diet-induced weight gain• Shrinks adipocyte size in white adipose tissue• Reduces lipid droplet count and volume in brown adipose tissue• Maintains normal brown adipose tissue morphology and function

Key Data

• Weight gain (high-fat diet model): 12.26 g (CCFM1219_2 group) vs. 21.1 g (model group) – 40.3% reduction• CCFM1219_1 group: 18.2 g weight gain – 13.7% reduction vs. model• Other intervention groups: no less than 19.14 g weight gain• Significantly increases proportion of small adipocytes (≤ 50 μm) in white adipose tissue

• Reduces proportion of large adipocytes (≥ 70 μm)

Patent

National Invention Patent – A postbiotic prepared from Lactobacillus rhamnosus for alleviating fatty liver and obesity and its application

Commercial Use

Used in collagen peptide probiotics, beauty & weight management blends; featured in 3 dietary fiber product SKUs (Red Bean, Quinoa & Chia, Purple Sweet Potato & Konjac)